A detailed history of American Century Companies Inc transactions in Regenxbio Inc. stock. As of the latest transaction made, American Century Companies Inc holds 74,872 shares of RGNX stock, worth $700,053. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74,872
Previous 64,105 16.8%
Holding current value
$700,053
Previous $1.35 Million 35.11%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$11.51 - $21.53 $123,928 - $231,813
10,767 Added 16.8%
74,872 $876,000
Q1 2024

May 14, 2024

BUY
$12.17 - $24.61 $183,268 - $370,601
15,059 Added 30.7%
64,105 $1.35 Million
Q4 2023

Feb 13, 2024

BUY
$12.89 - $20.82 $632,202 - $1.02 Million
49,046 New
49,046 $880,000
Q3 2023

Nov 13, 2023

SELL
$16.46 - $19.99 $785,948 - $954,502
-47,749 Reduced 17.99%
217,698 $3.58 Million
Q2 2023

Aug 14, 2023

SELL
$17.23 - $21.71 $1.99 Million - $2.5 Million
-115,304 Reduced 30.28%
265,447 $5.31 Million
Q1 2023

May 11, 2023

SELL
$18.08 - $24.55 $57,512 - $78,093
-3,181 Reduced 0.83%
380,751 $7.2 Million
Q4 2022

Feb 13, 2023

BUY
$20.4 - $24.73 $1.41 Million - $1.71 Million
69,214 Added 21.99%
383,932 $8.71 Million
Q3 2022

Nov 14, 2022

BUY
$22.29 - $35.04 $1.67 Million - $2.63 Million
75,053 Added 31.32%
314,718 $8.32 Million
Q2 2022

Aug 12, 2022

BUY
$19.35 - $35.04 $3.71 Million - $6.72 Million
191,668 Added 399.33%
239,665 $5.92 Million
Q1 2022

May 11, 2022

BUY
$24.62 - $34.31 $1.18 Million - $1.65 Million
47,997 New
47,997 $1.59 Million
Q1 2020

May 14, 2020

SELL
$21.5 - $54.2 $2.25 Million - $5.68 Million
-104,713 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$34.54 - $44.87 $1.47 Million - $1.9 Million
42,438 Added 68.15%
104,713 $4.29 Million
Q3 2019

Nov 13, 2019

BUY
$31.84 - $50.88 $115,451 - $184,490
3,626 Added 6.18%
62,275 $2.22 Million
Q2 2019

Aug 14, 2019

SELL
$42.0 - $59.29 $1.32 Million - $1.87 Million
-31,491 Reduced 34.94%
58,649 $3.01 Million
Q1 2019

May 14, 2019

BUY
$40.82 - $62.45 $1.69 Million - $2.59 Million
41,483 Added 85.26%
90,140 $0
Q4 2018

Feb 13, 2019

BUY
$39.11 - $75.15 $1.28 Million - $2.46 Million
32,734 Added 205.58%
48,657 $2.04 Million
Q3 2018

Nov 02, 2018

BUY
$65.0 - $82.15 $27,235 - $34,420
419 Added 2.7%
15,923 $1.2 Million
Q2 2018

Aug 08, 2018

BUY
$27.2 - $74.35 $421,708 - $1.15 Million
15,504 New
15,504 $1.11 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $404M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.